Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Precision Biosciences (DTIL) Shares Outstanding (Diluted Average) (2021 - 2025)

Historic Shares Outstanding (Diluted Average) for Precision Biosciences (DTIL) over the last 5 years, with Q3 2025 value amounting to $11.8 million.

  • Precision Biosciences' Shares Outstanding (Diluted Average) rose 6217.74% to $11.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $11.8 million, marking a year-over-year increase of 6217.74%. This contributed to the annual value of $6.9 million for FY2024, which is 7920.29% up from last year.
  • Per Precision Biosciences' latest filing, its Shares Outstanding (Diluted Average) stood at $11.8 million for Q3 2025, which was up 6217.74% from $11.0 million recorded in Q2 2025.
  • In the past 5 years, Precision Biosciences' Shares Outstanding (Diluted Average) registered a high of $110.8 million during Q3 2022, and its lowest value of $2.9 million during Q4 2022.
  • Its 5-year average for Shares Outstanding (Diluted Average) is $26.6 million, with a median of $7.1 million in 2024.
  • As far as peak fluctuations go, Precision Biosciences' Shares Outstanding (Diluted Average) tumbled by 9653.68% in 2023, and later soared by 8982.45% in 2024.
  • Quarter analysis of 5 years shows Precision Biosciences' Shares Outstanding (Diluted Average) stood at $58.7 million in 2021, then tumbled by 95.01% to $2.9 million in 2022, then soared by 31.11% to $3.8 million in 2023, then surged by 79.2% to $6.9 million in 2024, then skyrocketed by 71.68% to $11.8 million in 2025.
  • Its last three reported values are $11.8 million in Q3 2025, $11.0 million for Q2 2025, and $6.9 million during Q4 2024.